Liposome-entrapped streptomycin (SM) was compared with free SM for therapeutic efficacy against experimental salmonellosis in mice. All of the mice infected with the virulent strain of Salmonella enteritidis 116-54 died between days 5 and 7, and a dose of 20 mg of free SM per kg administered 24 h after the bacterial inoculation did not prolong the survival. In contrast, the same dose of SM entrapped in liposomes prolonged the survival for all mice to more than 15 days. The therapeutic activity paralleled the dose in the liposomes, and a dose as low as 1. Synthetic phospholipid bilayer vesicles, called liposomes, have attracted considerable interest as potent drug carriers (6). They are nontoxic and biodegradable and can protect the entrapped drugs from enzymatic attack or immune recognition until they reach the target cells. The toxicity of a drug itself can be reduced by this shielding in the liposomes. Upon intravenous injection, liposomes, especially multiplelayer vesicles, are removed rapidly by reticuloendothelial (RE) cells and at least partly localized in lysosomes, where they are slowly degraded (7, 13, 15) . This behavior of liposomes has some advantages for the treatment of diseases caused by intracellular parasites (5).
Synthetic phospholipid bilayer vesicles, called liposomes, have attracted considerable interest as potent drug carriers (6) . They are nontoxic and biodegradable and can protect the entrapped drugs from enzymatic attack or immune recognition until they reach the target cells. The toxicity of a drug itself can be reduced by this shielding in the liposomes. Upon intravenous injection, liposomes, especially multiplelayer vesicles, are removed rapidly by reticuloendothelial (RE) cells and at least partly localized in lysosomes, where they are slowly degraded (7, 13, 15) . This behavior of liposomes has some advantages for the treatment of diseases caused by intracellular parasites (5) .
In this study, experimental salmonellosis in mice was adopted as a model system of bacterial infection by intracellular parasites, and the therapeutic effect of streptomycin (SM) entrapped in liposomes was investigated. The results clearly indicated that the administration of liposomeentrapped SM could prolong the survival far more than the injection of free SM. Various applications of this method of selective drug delivery to RE cells were discussed.
MATERIALS AND METHODS
Mice. Male C57BL/6 mice were obtained from the Laboratory of Experimental Animals (Institute of Medical Science, University of Tokyo, Japan). The animals were maintained on laboratory chow and acidified chlorinated water and used when 2 to 4 months old.
Lipids. Egg yolk phosphatidylcholine was prepared by chromatography on alumina and silicic acid. Dipalmitoylphosphatidic acid and cholesterol were purchased from Sigma Chemical Co., St. Louis, Mo. Preparation of liposomes containing SM. Liposomes were * Corresponding author. prepared from a lipid mixture of egg yolk phosphatidylcholine (5 p.mol), cholesterol (5 ,umol) , and dipalmitoylphosphatidic acid (0.5 ,umol) (negatively charged). The dried lipid film, obtained on rotary evaporation and subsequent vacuum desiccation, was dispersed in 0.5 ml of an SM solution (streptomycin sulfate, Meiji Seika Co. Ltd., Tokyo, Japan) in saline at the following concentrations: 250 mg/ml for an injection of 20 mg/kg, 125 mg/ml for 10 mg/kg, 62.5 mg/ml for 5 mg/kg, 31.2 mg/ml for 2.5 mg/kg, and 15.6 mg/ml for 1.2 mg/kg. Unencapsulated SM was removed by centrifugation at 20,000 x g for 20 min at 4°C, and the final pellet was resuspended in 5 ml of saline. Under these experimental conditions the entrapment of SM in the liposomes was equivalent to about 2 to 4% of the original solution.
Measurement of SM entrapped in liposomes. The amount of SM entrapped in the liposomes was determined by the method of Boxer et al. (3) . Briefly, 0.5 ml of a liposome suspension was shaken with 2 ml of chloroform-methanol (2:1, vol/vol), and the upper (water) phase was recovered. A 0.25-ml portion of this water phase was evaporated and dissolved in 0.5 ml of saline. After the addition of 0.1 ml of 2 N NaOH, the solution was boiled for 3 min. Folin reagent (0.1 ml) and 0.2 ml of Na2CO3 were added, and the optical density was measured at 750 nm.
Evaluation of the therapeutic effect of SM in experimental salmonellosis. The virulent strain 116-54 of Salmonella enteritidis (10) suspension, diluted to an optical density of 0.31 at 520 nm, injections of 1 mg of SM per mouse in either the free or contained approximately 3 x i0 CFU/ml. Mice were inoculiposome-entrapped form. At various times thereafter, three lated intravenously (i.v.) with 3 x 102 CFU (calculated), a animals of each group were sacrificed, and blood was dose that was 10 times the minimal lethal dose and that was collected by cardiac puncture. Subsequently, the spleen, uniformly lethal within 5 to 7 days. In each experiment, the liver, and kidneys were excised and homogenized in saline.
number of viable cells actually injected was checked by After centrifugation at 1,500 x g, the concentration of SM in plating on Trypticase-soy agar, and the number ranged from the supernatant was determined from the inhibitory activity 2.4 x 102 to 4 x 102 CFU. Free SM or SM entrapped in toward the growth of Bacillus subtilis PCI219 (9). Estimation liposomes was injected i.v. 24 h after inoculation, and their of SM concentrations by measurement of the zones of therapeutic effects were evaluated on the basis of the proinhibition was kindly performed by Y. Matsuzaki and H. longation of survival.
Morishima, Nihon Banyu Seiyaku, Tokyo, Japan, Enumeration of S. enteritidis in spleens of infected mice. On various days after the administration of SM alone or SM in RESULTS liposomes on day 1, three animals per group were sacrificed. Effect of free SM in experimental salmonellosis. Before Their spleens were removed and disrupted in 5 ml of distilled starting the experiments with liposome-entrapped SM, variwater with a Waring blender. Viable organisms in the ous doses of free SM were administered to check whether spleens were enumerated by plating 0.3 ml of appropriately free SM itself could prolong the survival of infected mice. diluted samples on Trypticase-soy agar.
Since the 50% lethal doses (LD50s) of SM administered i.v.
Tissue distribution studies on SM. Mice were given i.v. and subcutaneously are around 150 to 300 and 600 to 1, 200 (Table 3) . In contrast, when administered in the liposomeentrapped form, the concentrations of SM in the spleen and liver were more than 100 times those of free SM. Effect of SM on the multiplication of S. enteritidis in the spleen. Experiments were designed to determine whether administration of SM entrapped in liposomes actually inhibited the multiplication of bacteria in the spleen. After injection of SM, free or entrapped in liposomes, in a dose of 20 mg/kg, the spleens were excised from three mice per group, and the total number of viable organisms was enumerated each day. The multiplication of bacteria was not affected significantly by administration of free SM, and the mice died between days 5 and 7 (Fig. 1) . In contrast, in the mice that received liposome-entrapped SM, the multiplication of S. enteritidis was completely suppressed, and the number of viable cells remained at around 103 per spleen. The inhibition of multiplication was still observed at day 10. DISCUSSION In this study experimental salmonellosis, a typical disease caused by intracellular bacteria, was successfully treated with SM when the drug was delivered in a liposomeentrapped form. The therapeutic effect paralleled the dose of SM in the liposomes, and even 1.2 mg of liposome-entrapped SM per kg slightly prolonged the survival, whereas 20 mg of free SM per kg did not have any significant effect. Furthermore, the advantage of using liposomes was more evident when a large dose of SM was used; i.e., entrapment in the liposomes reduced the toxic effect and prolonged the survival much mote. Two injections of SM in liposomes were found to be more efficient than a single administration. The therapeutic effect of liposome-entrapped SM was still observed in mice infected with a large inoculated dose (3 x 104 CFU).
It is clear from the SM distribution study that the therapeutic effect is at least partly due to the selective delivery of SM to RE cells. The increase in SM concentration in the spleen and liver was striking, and the levels reached more than 100 times those of free SM. Selective delivery of drugs to RE cells by liposomes has already been used for the treatment of diseases caused by intracellular parasites, especially leishmaniasis. In golden hamsters injected intracardially with Leishmania donovani, Alving et al. (2) found that a liposome-encapsulated antimonial drug was about 330 to 640 times more effective than the free antimonial drug in causing a drop in the death rate. New et al. (12) obtained similar results with NMR1 mice which were inoculated i.v. with the same parasite and treated with liposomal antimonial drugs. Furthermore, they demonstrated that the growth of cutaneous leishmaniasis could be reduced by i.v. administration of liposomes loaded with antimonial compounds (11) . Treatment with liposomeentrapped drugs was extended to trypanosomiasis (4) and malaria (1) , and significant improvement in the therapeutic effects was observed. Similarly, treatment of infectious diseases caused by intracellular bacteria can be enhanced by the use of liposomes. To our knowledge, however, there have been no papers reporting clear-cut observations, probably due to the lack of an appropriate experimental system.
There are many bacterial infections in which the main foci are RE cells, including typhoid fever, brucellosis, listeriosis, tularemia, and infection by Pasteurella spp. In the future, clinical application to these infectious diseases will be feasible. In brucellosis especially, daily oral administration of large doses of antibiotics over an extended period is required (for example, 2 to 3 g of tetracycline daily for several weeks).
Even with such large doses of drugs, the treatment is sometimes incomplete, and administration of such doses is particularly unsuitable for older patients and patients with renal diseases. In the veterinary field, brucellosis is more common and serious. Although we have to survey more carefully the side effects of liposomes in vivo, we have not found any macroscopic side effects and have never observed sudden death on i.v. injection. In this respect, liposome therapy will be immediately applicable to brucellosis in livestock.
Preferential delivery of drugs to RE cells is also applicable to immunodeficiency of phagocytes. In chronic granulomatous disease phagocytes retain their ingestive activity, but due to the loss of their killing function, catalase-positive bacteria, especially Staphylococcus aureus, can multiply in the cells (8) . The administration of large quantities of antibiotics cannot save the affected children from eventual death. Chronic granulomatous disease will be a good candidate for the application of liposome-entrapped drugs.
Liposomes will also be useful to augment RE cell functions. Reed et al. (14) demonstrated that macrophages activated by lymphokines encapsulated in liposomes are resistant to infection by Leishmania donovani subsp. chagasi. Thus, liposomes are attractive as a means of delivering various agents to RE cells to augment or modify their functions.
